Skip to content
10-K

Annual Report

CNBX PHARMACEUTICALS INC. CNBX

0001683168-25-008736

← back to feed
Filed
Dec 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Nov 20, 2025 553.96M sh
Shares Diluted FY 2025 · Aug 31, 2025 90.65M sh
Shares Diluted FY 2025 · Aug 31, 2024 30.25M sh
Operating Cash Flow FY 2025 · Aug 31, 2025 −$171.31K
Operating Cash Flow FY 2025 · Aug 31, 2024 −$244.27K
Cash And Equivalents FY 2025 · Aug 31, 2025 $15.11K
Cash And Equivalents FY 2025 · Aug 31, 2024 $26.42K
Stockholders Equity FY 2025 · Aug 31, 2025 −$2.5M
Stockholders Equity FY 2025 · Aug 31, 2024 −$2.48M
Stockholders Equity FY 2025 · Aug 31, 2023 −$2.02M
Current Liabilities FY 2025 · Aug 31, 2025 $2.51M
Current Liabilities FY 2025 · Aug 31, 2024 $2.51M
Current Assets FY 2025 · Aug 31, 2025 $18.44K
Current Assets FY 2025 · Aug 31, 2024 $31.38K
Total Assets FY 2025 · Aug 31, 2025 $18.44K
Total Assets FY 2025 · Aug 31, 2024 $31.38K
Eps Diluted FY 2025 · Aug 31, 2025 $0.00
Eps Diluted FY 2025 · Aug 31, 2024 −$0.02
Eps Basic FY 2025 · Aug 31, 2025 $0.00
Eps Basic FY 2025 · Aug 31, 2024 −$0.02
Sga Expense FY 2025 · Aug 31, 2025 $271.69K
Sga Expense FY 2025 · Aug 31, 2024 $518.43K
Rd Expense FY 2025 · Aug 31, 2025 $0
Rd Expense FY 2025 · Aug 31, 2024 $194.79K
Net Income FY 2025 · Aug 31, 2025 −$313.98K
Net Income FY 2025 · Aug 31, 2024 −$695.2K
Operating Income FY 2025 · Aug 31, 2025 −$271.69K
Operating Income FY 2025 · Aug 31, 2024 −$583.14K
Revenue FY 2025 · Aug 31, 2025 $0
Revenue FY 2025 · Aug 31, 2024 $130.07K